First Trust Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

First Trust Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-98,709	Closed	-$4.07M	–	2402
2015 Q2	$4.07M	Buy	98,709 +24,827	+34%	+$890K	0.01%	1133
2015 Q1	$2.6M	Buy	73,882 +20,424	+38%	+$691K	0.01%	1348
2014 Q4	$1.72M	Sell	53,458 -14,859	-22%	-$430K	0.01%	1534
2014 Q3	$1.92M	Buy	68,317 +10,645	+18%	+$324K	0.01%	1406
2014 Q2	$1.74M	Sell	57,672 -33,804	-37%	-$933K	0.01%	1430
2014 Q1	$2.53M	Buy	91,476 +78,414	+600%	+$2.05M	0.01%	1269
2013 Q4	$334K	Sell	13,062 -4,520	-26%	-$139K	﹤0.01%	2030
2013 Q3	$525K	Buy	+17,582	New	+$489K	﹤0.01%	1883

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

First Trust Advisors's BRLI Position: Q3 2015 in Review

First Trust Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 98,709 shares — an estimated $4.07M sold.

First Trust Advisors first reported a position in BRLI in Q3 2013 and held it in 8 quarters. The position peaked at $4.07M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

First Trust Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
First Trust Advisors sold 98,709 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.07M.
First Trust Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 8 quarters.
First Trust Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $4.07M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on First Trust Advisors's 13F filing for Q3 2015, filed 5 Nov 2015.